PaxMedica logo.jpg
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
11 avr. 2024 16h30 HE | PaxMedica, Inc.
TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...
1 CHPI 1080 copy.png
Waiting for new medicines in Canada, Europe, and the United States: Study finds Americans get better and faster access to innovative drugs
11 avr. 2024 10h30 HE | Canadian Health Policy Institute Inc.
Americans get better and faster access to innovative medicines compared to Europeans and Canadians.
1 CHPI 1080 copy.png
Access to new medicines in Canada, Europe, and the United States: Study finds less availability and longer waits for Canadian patients
11 avr. 2024 10h00 HE | Canadian Health Policy Institute Inc.
A recent study published by the Canadian Health Policy Institute examined the availability and wait times for access to new drugs.
US Gastroenterologis
US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
05 avr. 2024 09h17 HE | Spherix Global Insights
EXTON, PA, April 05, 2024 (GLOBE NEWSWIRE) -- As the first treatment to gain FDA approval for metabolic dysfunction-associated steatohepatitis (MASH), Madrigal Pharmaceuticals’ Rezdiffra...
PS phothi
IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
05 avr. 2024 09h00 HE | IR-Med, Inc.
Marks major milestone prior to launch in U.S. marketPressureSafe™ scanner and disposable pack both listed with FDAPressureSafe™ can support early detection of pressure injuries, potentially setting a...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages InMode Ltd. Investors with Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action – INMD
02 avr. 2024 15h42 HE | The Rosen Law Firm PA
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and...
NurExone logo2.png
NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update
02 avr. 2024 08h31 HE | NurExone Biologic Inc
NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INMD
28 mars 2024 11h28 HE | The Rosen Law Firm PA
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and...
enteralogo.png
Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
26 mars 2024 08h30 HE | Entera Bio Ltd.
JERUSALEM, March 26, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of orally delivered peptides, announced today that The American...
UAA.png
Congress Passes Bills Making Major Investments in Alzheimer’s
23 mars 2024 10h15 HE | UsAgainstAlzheimer's
Congress passes major investments in the fight against Alzheimer’s.